Verus Capital Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-842
Closed -$202K 301
2022
Q4
$202K Buy
+842
New +$189K 0.04% 247
2022
Q2
Sell
-842
Closed -$209K 306
2022
Q1
$209K Buy
+842
New +$211K 0.03% 299
2020
Q1
$22K Buy
242
+145
+149% +$18.8K 0.01% 777
2019
Q4
$14K Buy
+97
New +$13K ﹤0.01% 1020

Other funds holding HCA

Verus Capital Partners's HCA Position: Q1 2023 in Review

Verus Capital Partners sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 842 shares — an estimated $202K sold.

Verus Capital Partners first reported a position in HCA in Q4 2019 and held it in 4 quarters. The position peaked at $209K in Q1 2022. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

  • Verus Capital Partners reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
  • Verus Capital Partners sold 842 HCA Healthcare shares in Q1 2023, an estimated $202K.
  • Verus Capital Partners first reported a position in HCA Healthcare in Q4 2019 and held it in 4 quarters.
  • Verus Capital Partners's HCA Healthcare position peaked at $209K in Q1 2022.
  • 970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on Verus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.